Exploring drug targets based on disease-associated molecular mechanisms during development is crucial for the generation of novel prevention and treatment strategies for neurodevelopmental psychiatric conditions. We report that prefrontal cortex (PFC)-specific postnatal knockdown of DISC1 via in utero electroporation combined with an inducible knockdown expression system drives deficits in synaptic GABA A function and dendritic development in pyramidal neurons, as well as abnormalities in sensorimotor gating, albeit without profound memory deficits. We show for the first time that DISC1 is specifically involved in regulating cell surface expression of α2 subunit-containing GABA A receptors in immature developing neurons, but not after full maturation. Notably, pharmacological intervention with α2/3 subtype-selective GABA A receptor positive allosteric modulators during the early postnatal period ameliorates dendritic deficits and behavioral abnormalities induced by knockdown of DISC1. These findings highlight a critical role of DISC1-mediated disruption of postnatal GABA signaling in aberrant PFC maturation and function.
INTRODUCTION γ-aminobutyric acid type A (GABA A ) receptors are responsible for the majority of fast synaptic inhibition in the mature central nervous system. 1 During pre and early postnatal periods, GABA exerts a depolarizing and excitatory action, regulating multiple processes of neuronal maturation, including dendritic development. [2] [3] [4] Notably, dendritic abnormalities and deficits in GABA signaling, including alteration of GABA A receptors have been implicated in multiple neurodevelopmental psychiatric disorders, such as autism spectrum disorder, epilepsy and schizophrenia. [5] [6] [7] Accordingly, developmental GABA A receptor-mediated signaling is a unique molecular target to explore novel pharmacological treatment for these devastating conditions. Many pharmacological agents targeting GABA A receptors are clinically available. 5, 8 Most prominently, benzodiazepines have diverse therapeutic actions by enhancing GABA A receptor channel functions. 8 Nonetheless, due to their serious adverse effects including sedation, cognitive impairment, and potential for addiction/abuse, development of new positive modulators of GABA A receptors with lesser side effects is awaited. 5, 8 Many of these aversive effects are most likely due to activation of α1 subunit-containing GABA A receptor, 8, 9 leading researchers in academia and pharmaceutical companies to explore subtypeselective compounds without activity at α1 subunit-containing GABA A receptors. 5, 8 Although a number of subtype-selective GABA A receptor compounds have been tested in patients with neuropsychiatric conditions and animal models in adults, 8, [10] [11] [12] their action during earlier developmental phases has been poorly investigated.
In the present study, we explore the effect of postnatal intervention of subtype-selective positive allosteric modulators of α2/3-containing GABA A receptors on developmental deficits caused by knockdown of Disrupted-in-Schizophrenia-1 (DISC1), a genetic risk factor for major mental disorders. 13 DISC1 is involved in multiple cellular processes in the developing cerebral cortex. 14, 15 A functional interaction of DISC1 and NKCC1, a cationchloride cotransporter which plays a role in excitatory GABA function in hippocampal neurogenesis, has been demonstrated. 16 To explore the specific role of DISC1 for developmental GABA A receptor-mediated signaling in the prefrontal cortex (PFC) during postnatal periods, we have developed a modified conditional knockdown method by using in utero electoroporation. This system allows us to suppress DISC1 expression, specifically in pyramidal neurons in the PFC during postnatal periods. This technique is an alternative method to genetically engineered animals, since region-specific genetic deletion is currently impractical. [17] [18] [19] Our data demonstrates that postnatal knockdown of DISC1 impairs developmental GABA A receptormediated signaling, which can be reversed by subtype-selective positive allosteric small molecule modulators of GABA A receptors during the early postnatal period.
MATERIALS AND METHODS

In utero electroporation with a new electrode with a three-electrode configuration
In utero electroporation targeting the PFC region was performed by our published protocol with some modifications. 20 Pregnant C57/BL6 mice (Charles River, Wilmington, MA, USA) were anesthetized at embryonic day 14.5 (E14.5) by i.p. administration of a mixed solution of Ketamine HCl (100 mg kg − 1 ), Xylazine HCl (7.5 mg kg − 1 ) and Buprenorphine HCl (0.05 mg kg − 1 ). After the uterine horn was exposed by laparotomy, inducible short hairpin RNA (shRNA) to DISC1 (2 μg μl − 1 ) and CALNLgreen fluorescent protein (CALNL-GFP; 1 μg μl − 1 ) together with CAG-ER T2 CreER T2 (1 μg μl − 1 ) (molar ratio,~3:1:1) were injected into the bilateral ventricles with a glass micropipette made from a microcapillary tube (GD-1; Narishige, Tokyo, Japan). The embryo's head in the uterus was held between the custom-made electrode, consisting of one positive and two negative pole disc-type electrodes (Nepagene, Ichikawa, Japan). Electrode pulses (33 V; 50 ms) were charged four times at intervals of 950 ms with an electroporator (CUY21EDIT; Nepagene). After electroporation, the uterine horn was replaced in the abdominal cavity to allow the embryos to continue to develop. Brains extracted from DISC1 knockdown and control animals were assessed to confirm GFP expression in proper PFC regions after behavioral characterization. All experiments were performed in accordance with the institutional guidelines for animal experiments.
Dendrite analysis
Dendrites of GFP-positive pyramidal neurons in layer II/III in medial PFC at postnatal day 7 (P7) were analyzed morphologically, according to modifications of previously published protocols. 20, 21 Z stacks of images were collected with a confocal microscope (LSM 510 Meta, Zeiss, Oberkochen, Germany). Images of cells are taken using the × 40 oil-immersion objective lens as Z-series of images, averaged four times, taken at 0.8-μm intervals, 1024 × 1024 pixel resolution at a scan speed of 7 s per section. Acquisition parameters were kept the same for all scans. Images were reconstructed by compressing the Z stacks, and then analyzed by using NeuronJ, plug-in software for ImageJ (http://www.imagescience.org/meijering/software/neuronj/) to trace primary, secondary and tertiary branches of both apical and basal dendrites, and the number of dendrites per each category was calculated. To trace dendrites in a single GFP-positive neuron, the GFP-positive dendrites originating from other adjacent GFP-positive neurons were excluded based on observation of uncompressed Z-scan images. In each condition, 10 neurons from independent brain slices were analyzed in a blinded manner. For quantification of dendritic complexity in pharmacological in vivo rescue experiments, a region of interest was randomly selected (800-μm wide × 400-μm high) in layers I-III of medial PFC where GFPpositive cells were located. A Z-series of 10 images were collected at 6.02-μm depth intervals with a confocal microscope (LSM710NLO-Meta, Zeiss). Acquisition parameters were kept the same for all images. Intensity of the GFP signal in the whole area and cell bodies in the region of interest was measured from three images for each brain (total 10 brain sections for vehicle-treated mice and 10 brain sections from AZD7325-treated mice) by ImageJ software. The intensity ratio of GFP fluorescence of the processes (that is, GFP signal in cell bodies subtracted from that in the whole area) to GFP fluorescence in the whole area was analyzed. Dendritic structure in cortical neurons at 7 days in vitro (7 DIV) was analyzed by the previously published method with some modifications. 22 The images of GFP-positive neurons were acquired with a florescence microscope (LSM 510 Meta) in a blinded manner. We analyzed only neurons with typical morphological characteristics of pyramidal neurons (single axon and multiple dendrites) by excluding neurons which have atypical morphological characteristics, such as multiple axons or atypical neuronal processes. The total length of dendrites and dendrite branch number were determined by using NeuronJ, plug-in software for ImageJ. Dendritic complexity was analyzed by using Sholl analysis. The number of dendrites that crossed a series of concentric circles at 40-μm intervals from the soma was counted.
Treatment with GABA A -positive allosteric modulator compounds For in vitro assay, cortical neuron cultures expressing pSuper shRNA (Oligoengine, Seattle, WA, USA) were treated daily with AZD7325 or AZD6280 (0.1 μM final concentration) for 7 days. To assess their effect on dendritic development in vivo, AZD7325 (10 μmol kg − 1 body weight) with 40% (2-hydroxypropyl)-β-cyclodextrin or vehicle were injected i.p. into postnatal DISC1 suppression mice for 1 week starting at P4. Their pharmacological effects on dendritic structures and behavioral phenotypes were then assessed at P14 and 3 months old, respectively.
Details on the other experiments are provided in Supplementary Materials and Methods.
RESULTS
DISC1 is involved in cell surface expression of GABA A receptors in developing neurons, but not in mature neurons GABA A receptors are heteropentameric ligand-gated ion channels, which are mainly composed of two α, two β and one γ subunits in the brain. 23 We first examined whether knockdown of DISC1 induced by lentivirus-based shRNA affects total and cell surface expression of α, β and γ subunits of GABA A receptors in developing cultured cortical neurons. The knockdown effect of lentivirusbased shRNA to DISC1 on endogenous DISC1 was confirmed in developing cortical neurons (Supplementary Figure 1) . It is noted that we have previously confirmed knockdown effect of the same lentivirus-based shRNA to DISC1 on endogenous DISC1 in mature neurons. 24 Knockdown of DISC1 reduced cell surface expression of α2, β2, β3 and γ2 subunits, but not α1, α3 and α5 subunits, in developing cortical neurons at 7, whereas there were no changes in their total expression under these conditions ( Figure 1a and Supplementary Figure 2 ). This was reversed by co-expressing RNAi-resistant wild-type DISC1 (Figure 1a ). Decreased cell surface expression of these GABA A receptor subunits was also confirmed in the developing pyramidal neurons by immunocytochemical staining (Figure 1b) . Neither total nor cell surface expression of the cation-chloride cotransporters, NKCC1 and KCC2, which are two major determinants for the excitatory and inhibitory neuronal response to GABA, 2, 25 were changed (Supplementary Figure 2) . Notably, when DISC1 expression was suppressed in mature cortical neurons at 30 DIV, no difference in total or cell surface expression of these GABA A receptor subunits was observed between DISC1 knockdown and control neurons (Figure 1c ). These results suggest that suppression of DISC1 expression specifically impairs cell surface expression of α2 subunit-containing GABA A receptors during early developmental periods.
To monitor whether DISC1 is involved in regulation of intracellular calcium concentration via GABA signaling, calcium imaging experiments were conducted in developing cortical neuron cultures expressing the genetically encoded calcium indicator GCaMP3 together with shRNA to DISC1 or control scrambled shRNA, which carry a scarlet protein (Figure 1d) . Consistent with previous studies, bath application of GABA evoked increases of intracellular calcium in neurons expressing control shRNA at 7 DIV, 26 whereas knockdown of DISC1 diminished the effect of GABA administration on calcium influx (Figure 1e ). We confirmed that GABA-induced increase of intracellular calcium was mediated by GABA A receptor, as treatment with bicuculline, a GABA A receptor antagonist, blocks the effect (Figure 1e ).
Postnatal suppression of DISC1 expression by selective targeting of pyramidal neurons disrupts dendritic development in the PFC To investigate the effect of DISC1 in the PFC, specifically in the postnatal period, we utilized in utero electroporation with a previously developed Cre/loxP-mediated inducible gene expression system (Figures 2a and b) . 27 With this system, a stop codon flanked by two LoxP sites downstream from the CAG promoter is contained in microRNA30 (mir30)-based shRNA and overexpression plasmids. Cre recombinase fused to the mutated estrogen receptor is expressed under the control of the CAG promoter (CAG-ER T2 CreER T2 ), in which Cre is only active in the presence of 4-hydroxytamoxifen (4-OHT). We designed specific conditional shRNAs to DISC1 with independent target sequences, containing the sequences of which knockdown effects on DISC1 expression were previously characterized by conventional shRNAs and ] by knockdown of DISC1 in developing cortical neurons. Calcium imaging was assessed using the developing primary cortical neurons at 7 DIV transfected with GCaMP3 (green) as well as shRNAs to DISC1 (DISC1 RNAi) or scrambled controls (Control RNAi), which carry scarlet protein (red). Scale bar, 20 μm. (e) Bath application of GABA (50 μM) elicited increase in intracellular Ca 2+ concentration in neurons with control RNAi, whereas knockdown of DISC1 impaired Ca 2+ influx. Increase of calcium influx induced by GABA was prevented by treatment with bicuculline (10 μM). n = 10 neurons per condition. Bars represent averages of each group in three independent experiments (a and c). *Po 0.05, **P o0.01, ***P o0.001 determined by one-way ANOVA with post hoc Bonferroni test (a and e) and Student's t-test (c). ANOVA, analysis of variance.
lentivirus-mediated RNAi approaches. 20, 24, [28] [29] [30] We also made an inducible plasmid expressing HA-tagged RNAi-resistant wild-type mouse DISC1, in which four silent mutations are contained in the target sequence of shRNA to DISC1 (CALNL-HA-DISC1 R ). 28, 30 We confirmed the inducible knockdown effect of DISC1 on exogenously overexpressed wild-type mouse DISC1 and overexpression of RNAi-resistant wild-type mouse DISC1 in HEK 293 cells treated with 4-OHT (Supplementary Figure 3) , whose efficacies are comparable to lentivirus-based shRNA to DISC1 (Supplementary Figure 1) . To manipulate targeted gene expression in the bilateral PFC, we have developed a modified in utero electroporation method with a new electrode, which overcomes inefficiencies of our previous method which required a double electroporation step. 20 The new electrode has a three-pole configuration, composed of one positive pole and two negative poles, which were confirmed to target the bilateral PFC more precisely (Figure 2c ). In the developing cerebral cortex, pyramidal neurons originate from the ventricular zone and migrate radially into the cerebral cortex. 18, 19 Given that interneurons migrate tangentially from a ganglionic eminence 31 and glial cells are produced at late embryonic and early postnatal days, 32 the plasmid constructs introduced by in utero electroporation in the mid-embryonic periods are exclusively integrated into a lineage of pyramidal neurons as previously shown. 20 The efficacy of the modified technique with the new electrode was tested by a single electroporation of the inducible overexpression plasmid of CALNL-GFP and CAG-ER T2 CreER T2 into PFC at E14.5, followed by i.p. injection of 4-OHT at P2. We confirmed that GFP was extensively expressed in the bilateral PFC areas, simultaneously, at P7 (Figure 2c) .
We adapted this device to test the in vivo knockdown effect of DISC1 during the postnatal period by use of the Cre/loxP-mediated expression system. Inducible shRNA to DISC1 (DISC1 RNAi) or scrambled control shRNA (Control RNAi), together with CALNL-GFP and CAG-ER T2 CreER T2 , were electroporated into the developing PFC at E14.5, and pups were given 4-OHT at P2, when early postnatal period dendrite growth occurs. We have previously reported that in utero electroporation can be used to specifically target~20% of pyramidal neurons in layers II/III of the PFC. 20 Consistently, the present study found that GFP-positive cells are confined to CaMKII-positive pyramidal neurons,~20% of which are GFP-positive in layers II/III of the medial PFC (Supplementary Figure 4) . Knockdown of endogenous DISC1 in pyramidal neurons in the medial PFC was confirmed at P7 via immunohistochemistry, utilizing a previously characterized DISC1 antibody (Figure 2d ). 33 Dendritic structure is regulated by multiple mechanisms, including GABA A receptor-mediated signaling in early postnatal periods, 2, 3 and is a critical component for neuronal information processing through synaptic integration. 34 To evaluate the importance of DISC1 in dendritic growth specifically in post-migratory neurons, we monitored the effects of postnatal suppression of DISC1 expression on dendritic development in the medial PFC by use of the aforementioned Cre/loxP-mediated expression system via in utero electroporation. When observed at P7 in the medial PFC, a period of robust dendritic growth, numbers of apical and basal dendrites, as well as secondary branches of basal dendrites and tertiary branches of both apical and basal dendrites were reduced by the postnatal knockdown of DISC1, without deficits in radial neuronal migration (Figures 2e and f, and Supplementary Figure 5) . The reduction in number of dendrites and branches was seen in a knockdown effectdependent manner and reversed by inducible co-expression of RNAi-resistant wild-type DISC1 (Figures 2e and f) , suggesting that the observed phenotype is specifically due to knockdown of DISC1. We previously reported that conventional knockdown of DISC1 in the medial PFC starting at prenatal periods results in reduction of immunoreactivity of paravalbumin (PV), a marker of the fast spiking GABAergic interneurons. 20 When DISC1 expression was suppressed at the postnatal periods by inducible knockdown approaches, we observed no significant change in the number of PV-positive neurons in the medial PFC at young adulthood (Supplementary Figure 6) , indicating that knockdown of DISC1 in the postnatal periods is not sufficient for impairment of PVpositive neuron maturation.
Postnatal suppression of DISC1 expression in the PFC impairs developmental synaptic GABA function To examine the importance of postnatal expression of DISC1 for synaptic expression of α2 subunit-containing GABA A receptors under in vivo conditions, we analyzed cellular distribution of GABA A receptors and gephyrin, a GABA synaptic scaffold protein in the medial PFC of mice with postnatal suppression of DISC1 expression. Although inducible knockdown of DISC1 does not affect the number of gephyrin puncta and colocalization of gephyrin and vesicular GABA transporter, a presynaptic marker for GABAergic synapses, a reduction in colocalization of gephyrin and α2 subunit of GABA A receptors was observed in the dendrites of developing pyramidal neurons (Figures 3a and b) . These results indicate that knockdown of DISC1 reduces expression of α2 subunit in the GABAergic synapses in a cell-autonomous manner.
Postnatal suppression of DISC1 expression may affect synaptic GABA A receptor function. To test this idea, synaptic GABA A receptor function was measured by whole-cell electrophysiology in postnatal PFC brain slices of inducible DISC1 knockdown mice and control mice with inducible scrambled control shRNA. Consistent with immunohistochemical data (Figures 3a and b) , we found significant reductions in the amplitude of GABAmediated miniature postsynaptic currents (GABA-mediated mPSCs) in neurons with postnatal suppression of DISC1 expression under pharmacological blockade of NMDA receptors (100 μM DL-AP5), AMPA receptors (10 μM NBQX), and sodium channels (1 μM TTX), whereas no difference was observed in the frequency of GABA-mediated mPSCs between both groups of mice (Figures 3c and d) .
Postnatal suppression of DISC1 expression in the PFC impairs sensorimotor gating, albeit without profound memory deficits, in young adulthood We next examined whether postnatal knockdown of DISC1 in the PFC results in long lasting behavioral alterations. Given that changes in body weight may reflect nonspecific developmental abnormalities and resultant behaviors, we examined differences in body weight between inducible DISC1 knockdown mice and control mice with inducible scrambled control shRNA at 3 months of age, but observed no difference (Supplementary Figure 7) . Animals were then evaluated in the open field test and elevated plus maze test to measure locomotor activity and anxiety-related behavior, which might confound assessment of cognitive behaviors. There was no difference in either test between both . (c) Three-electrode configuration for in utero electroporation to target the bilateral PFC. By using the custom-made electrode (upper panels), CALNL-GFP was simultaneously electroporated into the right and left side of PFC at embryonic day 14.5 (E14.5) and GFP expression was confirmed in the bilateral PFC at postnatal day 7 (P7) (lower panels). Scale bar, 1 mm. (d) Inducible DISC1 RNAi or Control RNAi were co-introduced with CAG-ER T2 CreER T2 and CALNL-GFP in the PFC at E14.5 followed by intraperitoneal injection of 4-OHT at P2. Efficient suppression of DISC1 immunoreactivity (red traced by dotted white lines) in GFP-positive pyramidal neurons (green) is shown in the medial PFC at P7. n = 30 neurons from three mice per condition. Scale bar, 10 μm. (e and f) Mice with postnatal knockdown of DISC1 in pyramidal neurons of the medial PFC show impaired dendritic development, but not radial neuronal migration. Total number of dendrites and dendrite branches in each category (primary, secondary and tertiary of apical and basal dendrites) was analyzed at P7. DISC1 RNAi has a stronger effect than RNAi-2. Inducible co-expression with RNAi-resistant DISC1 (red) normalized dendritic abnormalities induced by knockdown of DISC1. In each condition, 10 neurons from independent brain slices were analyzed in a blinded manner. Traced dendrites were categorized as primary apical (yellow) and basal (red), secondary apical (blue) and basal (cyan) dendrites, as well as tertiary apical (green) and basal (yellow) dendrites, respectively. Only neurons with typical morphological characteristics of pyramidal neurons (single thick axon arising from the basal side of the soma with multiple basal dendrites and apical dendrites extending vertically to layer I) were analyzed. Green, GFP; blue, nucleus. Scale bar, 100 μm (upper panels), 20 μm (middle panels). *P o0.05, **P o0.01 and ***P o0.001 determined by Student's t-test groups of mice (Figures 4a and b) . Our previous study established that knockdown of DISC1 in the PFC starting from the embryonic period resulted in deficits in cognitive function and sensory information processing, assessed by the novel object recognition test and prepulse inhibition test (PPI). 20 To examine whether postnatal suppression of DISC1 expression is sufficient to elicit these behavioral abnormalities, novel object recognition test and PPI were performed in 3-month-old animals with inducible knockdown of DISC1. In the novel object recognition test, no difference was observed between inducible DISC1 knockdown mice and controls for total exploration time and exploratory preference of the novel object and its location, suggesting that postnatal suppression of DISC1 expression in the PFC has no major impact on object and spatial recognition memory (Figure 4c and Supplementary Figure 8) . Of note, we found a significant increase in the baseline of acoustic startle response as well as a reduction in PPI with prepulses of 74 dB, 78 dB and 82 dB in the inducible DISC1 knockdown mice (Figures 4d and e) , indicating that postnatal expression of DISC1 in the PFC is required for normal sensorimotor gating. To examine the neuronal circuit mechanisms underlying these behavioral alterations induced by knockdown of DISC1, expression of c-Fos, an immediate early gene, was evaluated in several brain regions where we demonstrated existence of direct projections from GFP-positive pyramidal neurons in the PFC after the mice were given the pulse in PPI experiments (Supplementary Figure 9a) . These brain areas include the nucleus accumbens core and shell as well as the basolateral amygdala, which are implicated in both the acoustic startle response and PPI. [35] [36] [37] We found that induction of c-Fos in the basolateral amygdala, but not in the nucleus accumbens core and *** ** , and 7-day treatment with positive allosteric modulators of α2/3-containing GABA A receptors, AZD7325 (0.1 μM) and AZD6280 (0.1 μM), in primary cortical neuron expressing DISC1 RNAi carrying GFP protein (green). Traced dendrites were depicted as white lines (lower panels). Blue, nucleus. Scale bar, 100 μm. (b) Quantification of dendritic morphometry demonstrates that reduction of dendrite growth and branches as well as altered dendrite complexity induced by knockdown of DISC1 was ameliorated by co-expression with RNAi-resistant DISC1, in which the effect is comparable to treatment with AZD7325 and AZD6280. We analyzed only neurons with typical morphological characteristics of pyramidal neurons (single axon and multiple dendrites). n = 7 per condition. (c) Representative image showing dendritic structure of GFPlabeled pyramidal neurons in medial PFC from postnatal DISC1 suppression mice after intraperitoneal injection of AZD7325 (10 μmol kg − 1 body weight) or vehicle for 1 week in the early postnatal period. Ratio of GFP fluorescence intensity in dendrites to total GFP fluorescence intensity was increased in AZD7325-treated inducible DISC1 knockdown mice, compared with those of vehicle-treated ones. Blue, nucleus. Scale bar, 100 μm. Ten brain slice images per condition were analyzed in a blinded manner. (d) Startle response to 120 dB acoustic pulse was increased in the postnatal DISC1 knockdown mice compared with the control mice, and this excessive response was normalized by early postnatal treatment with AZD7325. (e) Impairment of prepulse inhibition in the postnatal DISC1 knockdown mice was rescued by AZD7325 treatment, significantly ameliorated at 74 dB prepulse and partially ameliorated at 78 dB. *Po 0.05, **P o0.01 and ***P o0.001 determined by one-way ANOVA with post hoc Bonferroni test (b-e). ANOVA, analysis of variance; GFP, green fluorescent protein; PFC, prefrontal cortex.
Early postnatal GABA A modulation reverses deficits in neuronal maturationshell, was impaired by postnatal knockdown of DISC1 (Figure 4f) . Importantly double-labeling experiments revealed that observed induction of c-Fos elevation in the basolateral amygdala is occurring predominantly in GAD67-positive GABAergic neurons (Supplementary Figure 9b) .
Subtype-selective positive allosteric modulators of α2/3-containing GABA A receptors reverse dendritic abnormalities induced by suppression of DISC1 in developing cortical neurons Results thus far indicate that postnatal knockdown of DISC1 causes a reduction in cell surface expression of α2 subunitcontaining GABA A receptors, impaired postsynaptic GABA A receptor signaling, dendritic abnormalities in developing pyramidal neurons, and behavioral alterations including excessive startle response and deficits in PPI. We therefore investigated whether pharmacological activation of GABA A receptors might overcome these abnormalities due to suppression of DISC1 expression. A variety of subtype-selective compounds of GABA A receptors have recently been synthesized. 8 We tested the potential of two novel subtype-selective positive allosteric modulators of α2/3-containing GABA A receptors (AZD7325 and AZD6280) (Supplementary Figure  10) to overcome dendritic alterations induced by knockdown of DISC1 in developing cortical neuron cultures. These compounds were previously shown to have modest efficacy on α2/3-containing GABA A receptors and low efficacy on α1-or α5-containing subtypes. 38 These observations were confirmed by electrophysiological characterization in Xenopus oocytes expressing α1-, α2-, α3-or α5-containing GABA A receptors (Supplementary Figure 11) . Application of either AZD7325 or AZD6280 rescued dendritic abnormalities induced by knockdown of DISC1, including both numbers of branches as well as total dendritic length and complexity; this effect is comparable to that of overexpression of RNAi-resistant wild-type DISC1 (Figures 5a and b and Supplementary Figure 12 ). We also found that treatment with AZD7325 does not affect impaired cell surface expression of α2 subunit induced by knockdown of DISC1 (Supplementary Figure 13) . We then examined whether transient administration of AZD7325 during the early postnatal period ameliorates observed neuronal and behavioral deficits in inducible DISC1 suppression mice. AZD7325 (10 μmol kg − 1 body weight) and vehicle were administered i.p. daily for 1 week starting from P4. Dendritic quantity in the mPFC was measured at P14 by comparing fluorescence intensity. We observed that transient pharmacological early intervention with AZD7325 reversed dendritic deficits caused by postnatal DISC1 suppression (Figure 5c ). The effect of treatment with AZD7325 on abnormalities in acoustic startle response and PPI was then assessed in 3-month-old animals. In addition to normalization of the elevated startle response, a reduction in PPI with prepulses of 74 dB was rescued by early postnatal treatment with AZD7325 (Figures 5d and e) .
DISCUSSION
Our data indicate that DISC1 is involved in regulating cell surface expression of α2 subunit-containing GABA A receptors and postsynaptic GABA A receptor signaling during early postnatal periods. Given that knockdown of DISC1 has no effect on total protein expression levels of GABA A receptors, reduction of cell surface expression of GABA A receptors is unlikely to result from slow maturation of these neurons caused by knockdown of DISC1. Although molecular mechanisms determining how DISC1 is involved in cell surface expression of α2 subunit-containing GABA A receptors in developing neurons are still unclear, it is worth noting that DISC1 has been reported to bind to the kinesin family member 5 that regulates GABA A receptor intracellular transport. 39, 40 Thus DISC1 may participate in the targeting of these receptors to the cell surface or specific neuronal compartments. Multiple DISC1-associated signaling pathways are involved in dendritic growth. 14, 15, 41 However, our data demonstrate that pharmacological potentiation of GABA A receptormediated signaling rescued dendritic abnormalities caused by knockdown of DISC1, suggesting that DISC1 may be involved in developmental control of dendrite growth through modulation of GABA signaling. Of note, the effect of DISC1 on cell surface expression of GABA A receptors is specific to the developmental phase and treatment with subtype-selective positive allosteric modulators of α2/3-containing GABA A receptors during the early postnatal period alleviated dendritic and behavioral abnormalities, though it remains an open question whether the observed abnormalities induced by knockdown of DISC1 could also be rescued by other subtype-selective modulators.
Based on our results, we assume that reduced GABAergic inhibition in the basolateral amygdala may contribute to dysfunction in medial PFC-basolateral amygdala circuit that underlies the observed behavioral changes. Changes in the activity of circuits connecting these brain regions may represent a potential mechanism that contributes to the enhanced acoustic startle response and impaired sensorimotor gating caused by postnatal knockdown of DISC1. This hypothesis is supported by previous findings that pharmacological blockade of GABA A receptors in the basolateral amygdala leads to an enhanced startle response and deficits in PPI. 42 We have previously demonstrated that knockdown of DISC1 beginning at prenatal periods leads to abnormalities in dopaminergic circuit maturation. 20 Given that mesocortical and mesolimbic dopaminergic projections are involved in regulating sensorimotor gating, 35 it would be interesting to elucidate how postnatal knockdown of DISC1 in the PFC affects dopaminergic circuits, whose disturbance may also underlie excess acoustic startle response and PPI deficits observed in our mouse models.
Pharmacological targeting of excitatory GABA signaling during early development has recently been reported. Tyzio et al. 43 have reported that maternal treatment with bumetanide, a NKCC1 blocker, ameliorates autism-associated electrophysiological and behavioral characteristics in animal models with in utero exposure to valprorate and mouse model carrying the fragile X mutation. In contrast, perinatal treatment with bumetanide has detrimental effects on dendritic maturation and behaviors. 44 The discrepancy between these studies cautions us that dose and timing of pharmacological modulators to alter developmental GABA signaling is critical to obtain beneficial effects on disease conditions.
To the best of our knowledge, this is the first study demonstrating the utility of a conditional knockdown system with in utero electroporation for gene targeting in a spatial and temporal manner. This approach allowed us to segregate a role for DISC1 in dendritic development, independent from the secondary effects of DISC1 on dendrites caused by disturbed cell proliferation and neuronal migration. DISC1 is involved in diverse cellular processes in the developing cerebral cortex. 14, 15 These include cell proliferation, neuronal migration and dendrite growth, which have been demonstrated in various rodent models. 20, [28] [29] [30] [45] [46] [47] [48] [49] [50] [51] [52] Nonetheless, how DISC1-mediated pathways in specific developmental periods are involved in these phenotypes is unclear. Here we report that suppression of DISC1 expression in the PFC in the postnatal period impaired developmental synaptic GABA A receptor function and was sufficient to evoke deficits in dendritic growth and sensorimotor gating in young adulthood. Similarly, indirect disruption of early GABA excitatory action caused by perinatal treatment with bumetanide results in deficits in dendritic formation in cortical neurons and sensorimotor gating. 44 Although it is laboriously difficult to investigate effective therapeutic strategies to restore function due to a genetic predisposition during brain development in humans, our study provides proof-of-principle that pharmacological intervention during specific postnatal periods may be critical. Thus, mechanism-based pharmacological application during development is warranted to be tested in animal models.
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